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SUMMARY	  
Despite often being classified as selfish or junk DNA, transposable elements (TEs) are a 
group of abundant genetic sequences that significantly impact on mammalian development 
and genome regulation. In recent years, our understanding of how pre-existing TEs affect 
genome architecture, gene regulatory networks and protein function during mammalian 
embryogenesis has dramatically expanded. In addition, the mobilization of active TEs in 
selected cell types has been shown to generate genetic variation during development and in 
fully differentiated tissues. Importantly, the ongoing domestication and evolution of TEs 
appears to provide a rich source of regulatory elements, functional modules and genetic 
variation that fuels the evolution of mammalian developmental processes. Here, we review 
the functional impact that TEs exert on mammalian developmental processes and how the 
somatic activity of TEs can influence gene regulatory networks.	  
 
KEY WORDS: Retrotransposon; endogenous retrovirus; LINE-1; genome regulation; genetic 
variation	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Introduction	  
Genomes are the habitat in which genes reside, and their complexity is an indication 
of the number of biological processes that are required during the life of an organism. 
Comparative genomic studies have revealed that the proportion of the genome occupied by 
genes decreases as biological complexity increases (Boeke and Devine, 1998). Intriguingly, 
the opposite is observed for transposable elements (TEs) (Boeke and Devine, 1998), which 
are pieces of DNA that can move within genomes. Copies of these elements are typically 
interspersed throughout the genomes of most organisms examined to date. Up to 70% of the 
human genome is derived from TEs (de Koning et al., 2011), while genes occupy less than 
2% (Lander et al., 2001). These data imply that there has been a significant activity of TEs 
during evolution but that most of the genetic changes caused by TEs are not detrimental. 
Rather, the high percentage of TE-derived sequences in mammalian genomes could indicate 
their inherent potential to create and diversify biological processes, as proposed 60 years 
ago by McClintock, Britten and Davidson (Britten and Davidson, 1969; McClintock, 1956). 
The proposal that TEs have a present day function in host genomes to provide cis-regulatory 
elements that co-ordinate the expression of groups of genes (Britten and Davidson, 1969) is 
starting to be tested on a genome-wide scale with the advent of next generation sequencing. 
Furthermore, recent findings showing that TEs mobilize much more frequently in 
development than previously anticipated suggest that these sequences may have additional 
present-day functions in host genomes (recently reviewed in (Hancks and Kazazian, 2016; 
Munoz-Lopez et al., 2016; Richardson et al., 2015)). 
In this Review, we cover the functional impact that TEs exert on gene regulatory 
networks operating during mammalian embryogenesis but also in somatic adult tissues. We 
also review some of the recent evidence outlining the myriad of ways that TEs can further 
increase functional variability in mammalian genomes, which may shed some light on why 
these elements have become so abundant in mammalian genomes.	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Types of TEs in the mammalian genome	  
There are several classes of TEs (Fig. 1) that vary with regards to their structure, 
impact and regulation in mammalian genomes (as reviewed in (Hancks and Kazazian, 2016; 
Munoz-Lopez et al., 2016; Richardson et al., 2015)). These include DNA transposons as well 
as retrotransposons, which can be further sub-divided into long terminal repeat (LTR) 
retrotransposons and non-LTR retrotransposons (Hancks and Kazazian, 2016; Munoz-Lopez 
et al., 2016; Richardson et al., 2015).  
Briefly, approximately 3% of a typical mammalian genome is made of DNA 
transposons (Lander et al., 2001; Waterston et al., 2002). However, with the exception of 
some bat species, DNA transposons no longer mobilize in mammals (Mitra et al., 2013; Ray 
et al., 2007). In contrast, LTR retrotransposons and non-LTR retrotransposons comprise 
more than 40% of a typical mammalian genome and are still active in most mammalian 
species (Hancks and Kazazian, 2016; Lander et al., 2001; Richardson et al., 2015). LTR 
retrotransposons are similar to retroviruses in terms of their structure and mechanism of 
retrotransposition (Fig. 2A) and are hence often called endogenous retroviruses (ERVs; 
reviewed in (Mager and Stoye, 2015)). Full-length ERVs are flanked by LTRs that promote 
the transcription and maturation of ERV RNAs, and they also contain functional Gag and Pol 
genes, which encode structural proteins and enzymes involved in retrotransposition. 
However, ERVs often lack a functional Env gene, which encodes the envelope protein that 
retroviruses typically use to exit cells (Lee and Bieniasz, 2007). Furthermore, recombination 
between LTRs occurs frequently, deleting the intervening internal ERV sequence and 
generating solo LTRs (Belshaw et al., 2007). The mobilization of active ERVs involves an 
RNA intermediate and a copy-and-paste mechanism that is similar to the initial steps of 
retroviral infection (Fig. 2A). ERV mobilization in mice is responsible for nearly 10% of 
spontaneous mutations in this species; by contrast, ERVs generally no longer mobilise in 
humans (Mager and Stoye, 2015; Maksakova et al., 2006). However, recent reports have 
identified polymorphic HERV-K insertions in humans ((Wildschutte et al., 2016), reviewed in 
(Hohn et al., 2013)) suggesting recent mobilisation activity and the possibility that some 
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HERV-K copies might retain capability to mobilize in present day humans. Hundreds of 
different types of ERVs are present in a typical mammalian genome, some of which are 
autonomous and encode the functional retroviral proteins required for their mobilization (Fig. 
2A), while others are non-autonomous and rely on retroviral proteins encoded by active 
ERVs to mobilize (Mager and Stoye, 2015; Maksakova et al., 2006). Notably, two types of 
ERVs – IAP elements and MusD/ETn - appear to be the most active ERVs in mice and their 
activity can vary among inbred mouse strains (Maksakova et al., 2006).	  
Mammalian non-LTR retrotransposons are exemplified by long interspersed element 
class 1 (LINE-1 or L1) retrotransposons, which are the only active autonomous 
retrotransposons in the human genome (Hancks and Kazazian, 2016; Munoz-Lopez et al., 
2016; Richardson et al., 2015). LINE-1 retrotransposons make up 17% of the human 
genome and, although most LINE-1s are molecular fossils that have lost their ability to move, 
80-100 LINE-1 copies retain retrotransposition potential (Beck et al., 2010; Brouha et al., 
2003). In mice, LINE-1 elements comprise a similar fraction of the genome to humans 
(Waterston et al., 2002) but a few thousand LINE-1 elements may retain the capacity to 
retrotranspose (reviewed in (Richardson et al., 2015)). Mammalian genomes also contain 
numerous short interspersed element (SINE) non-LTR retrotransposons, exemplified by Alu 
and SVA (SINE-VNTR-Alus) in the human genome (Lander et al., 2001). SINEs are non-
autonomous retrotransposons that use LINE-1 proteins in trans to mobilise (Dewannieux et 
al., 2003; Dewannieux and Heidmann, 2005; Hancks et al., 2011; Raiz et al., 2011). Non-
LTR retrotransposons also move by a copy-and-paste mechanism (Fig. 2B), but one that is 
fundamentally different from that used by LTR-retrotransposons (Richardson et al., 2015). 
Notably, active LINE-1 elements code for two protein products termed Open Reading Frame 
(ORF) 1 and ORF2 that are strictly required for LINE-1 mobilization (Moran et al., 1996). 
While ORF1 encodes an RNA binding protein with nucleic acid chaperone activity (Hohjoh 
and Singer, 1997; Martin and Bushman, 2001), ORF2 codes for a protein with endonuclease 
and reverse transcriptase activity (Feng et al., 1996; Mathias et al., 1991) (Figs. 1 and 2).	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The regulation of TE activity in the mammalian genome	  
The activity of TEs is tightly regulated in mammals to control the number of 
insertions accumulated in genomes (Hancks and Kazazian, 2016; Munoz-Lopez et al., 2016; 
Richardson et al., 2015). Mechanisms that restrict TE expression and mobilization are likely 
to be particularly important in germ cells, as well as in the pluripotent cells in early embryos 
that act as germ cell precursors, as new TE insertions in these cells can potentially be 
transmitted to the next generation and increase TE copy number during evolution (Crichton 
et al., 2014). However, the differential activity of these restriction mechanisms in different cell 
types can influence the ability of TEs to impact gene regulatory networks. Given that these 
topic have been extensively reviewed recently (Goodier, 2016; Hancks and Kazazian, 2016; 
Heras et al., 2014; Munoz-Lopez et al., 2016; Pizarro and Cristofari, 2016; Richardson et al., 
2015), below we provide just an overview of some of the main mechanisms used to control 
TE activity.  
 
Transcriptional repression of TEs  
Transcriptional repression is a major mechanism of defense against 
retrotransposons. In mice, the transcriptional regulation of LINE-1 and ERVs is dynamic 
during development, and different mechanisms contribute to the repression of these TEs in 
different cell types. Histone modifications and DNA methylation, for example, both play 
important roles, although the relative importance of each of these mechanisms may depend 
on both the TE and the cell type (Crichton et al., 2014; Gerdes et al., 2016; Rowe and Trono, 
2011; Schlesinger and Goff, 2015). DNA methylation plays a role in repressing both mouse 
and human LINE-1 elements, and some mouse ERVs including IAP elements (Bourc'his and 
Bestor, 2004; Karimi et al., 2011; Walsh et al., 1998). Multiple histone modifications, 
including methylation at histones H3K4, H3K9, H2A/H4R3 and H3K27 as well as histone 
acetylation, have also been implicated in TE transcriptional repression (Brunmeir et al., 2010; 
Di Giacomo et al., 2014; Karimi et al., 2011; Kim et al., 2014; Leeb et al., 2010; Macfarlan et 
al., 2011; Matsui et al., 2010; Reichmann et al., 2012). One of the major histone 
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modifications used to repress a large number of TEs in pluripotent mouse embryonic stem 
cells (ESCs) is H3K9me3 (Karimi et al., 2011; Matsui et al., 2010; Rowe et al., 2010). This 
modification is largely deposited at TE sequences by the histone methyltransferase Setdb1, 
which is recruited to TEs by Krüppel-associated box-containing zinc-finger proteins (KRAB-
ZFPs) and their associated co-repressor KAP1 (Castro-Diaz et al., 2014; Ecco et al., 2016; 
Karimi et al., 2011; Matsui et al., 2010; Rowe et al., 2010; Wolf and Goff, 2009; Wolf et al., 
2015b). KRAB-ZFPs provide the sequence specificity to target repression to TEs, and some 
KRAB-ZFPs that target specific types of TE have been identified (Castro-Diaz et al., 2014; 
Ecco et al., 2016; Wolf and Goff, 2009; Wolf et al., 2015a). However, as a reflection of the 
parasite/host battleground, young and presumably active TEs escape KAP1-mediated 
silencing as KRAB-ZFPs have not yet evolved to target these sequences (Castro-Diaz et al., 
2014; Jacobs et al., 2014). Thus, KAP1 does not control expression of all mammalian TEs 
and alternate mechanisms exist to control the expression of young and active TEs (Castro-
Diaz et al., 2014; Jacobs et al., 2014). Intriguingly, tissue-specific expression of some KRAB-
ZFPs may underlie tissue-specific host gene expression in somatic tissues through their 
effects on TEs (see below) (Ecco et al., 2016).	  
 
Co-transcriptional repression of TE expression  
In addition to transcriptional repression, splicing has been shown to regulate LINE-1 
mobilization in cultured cell lines and somatic tissues by generating non-functional LINE-1 
transcripts (Belancio et al., 2006; Perepelitsa-Belancio and Deininger, 2003). In addition, 
Microprocessor – a complex that naturally processes structured pre-microRNAs (pre-
miRNAs) to generate miRNAs - can also process LINE-1 and SINE RNAs, thereby reducing 
their retrotransposition activity (Heras et al., 2014; Heras et al., 2013).  	  
Post-transcriptional control of TEs  
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A number of viral restriction factors have also been shown to act post-
transcriptionally to regulate the activity of retrotransposons (reviewed in (Goodier, 2016; 
Pizarro and Cristofari, 2016)). Some factors such as RNaseL (Zhang et al., 2014), SAMHD1 
(Zhao et al., 2013), hnRNPL and nucleolin (Peddigari et al., 2013), MOV10 (Goodier et al., 
2012), UPF1 (Taylor et al., 2013), Pin1 (Cook et al., 2015) and ZAP (Goodier et al., 2015) 
has been implicated in post-transcriptionally regulating TE RNAs or post-translationally 
modifying TE proteins. Others including SAMHD1 (Zhao et al., 2013) and PCNA (Taylor et 
al., 2013) have been implicated in modulating reverse transcription. Finally, APOBEC 
proteins (Richardson et al., 2014b; Schumann, 2007) and PCNA (Taylor et al., 2013) have 
been shown to interfere with later steps of the retrotransposition cycle. We speculate that the 
pattern of expression of TE-restriction mechanisms may impact human biology, as this will 
establish a level of TE activity in different cell types. Furthermore, the use of proteomics has 
resulted in a list of host factors that interact with LINE-1 and may regulate its 
retrotransposition (Goodier et al., 2013; Moldovan and Moran, 2015; Taylor et al., 2013). 
However, the role of most of these identified LINE-1 interactors remains to be determined 
and future studies will help to understand the dynamic interaction between TEs and cellular 
host factors.	  
 
TEs can impact developmental processes via various mechanisms	  
When expressed, TEs can affect developmental processes either via their gene 
products, which can influence the behavior of host cells, or through new insertions that cause 
genetic changes in the host genome (Fig. 3). Not surprisingly, therefore, the dysregulated 
expression of TEs has been linked with defects in various developmental processes in mice, 
including aberrant proliferation of male germ cells (Galli et al., 2005), defects in oogenesis 
(Malki et al., 2014; Su et al., 2012), disruption of homologous chromosome synapsis during 
meiosis (reviewed in (Crichton et al., 2014; Ollinger et al., 2010)), activation of the unfolded 
protein response during differentiation of B lymphocytes (Pasquarella et al., 2016), and 
inappropriate activation of innate immune responses (Herquel et al., 2013; Stetson et al., 
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2008). On the other hand, new TE insertions into genes can act as insertional mutagens in 
mammalian genomes and interfere with gene function (Fig. 3, reviewed in (Hancks and 
Kazazian, 2016; Heras et al., 2014; Munoz-Lopez et al., 2016; Pizarro and Cristofari, 2016; 
Richardson et al., 2015)). Such insertions can, for example, introduce actively transcribing 
promoters into genes and cause transcriptional interference. They can also induce premature 
termination of transcription via the incorporation of TE-derived polyadenylation sites 
(Perepelitsa-Belancio and Deininger, 2003). In addition, inefficient transcriptional elongation 
through the AT-rich LINE-1 sequence can modulate gene expression levels (Han et al., 
2004). TE insertions can also introduce TE-derived splice acceptor or donor sites that alter 
splicing, generating non-functional or nonsense transcripts (Belancio et al., 2006) (Fig. 3A), 
or can be incorporated into mRNAs and introduce frameshifts or premature termination 
codons (Fig. 3A). However, it should be noted that many of these mechanisms can also 
potentially confer new properties and functions to a host gene rather than simply inactivate it 
(Fig. 3B-D). Below, we examine how the present day functions of TEs can affect 
developmental genes and processes in mammals. 
 
TEs as promoters that drive the transcription of host genes 	  
TEs contain transcription factor binding sites that promote transcription by RNA 
polymerase II (in the case of DNA transposons, ERVs, LINE-1s, primate SVAs and even 
SINEs (Lai et al., 2009)) or RNA polymerase III (in the case of short SINEs such as human 
Alu, and murine B1 and B2). As such, if a TE integrates into or near host genes, its 
promoters can drive the expression of novel transcripts that encompass part of the coding 
region (Fig. 3B-D). The co-option of TE-derived sequences as gene promoters can allow a 
gene to be expressed in new cell types or contexts (Fig. 3B, D) and can generate truncated 
or extended protein products, potentially allowing host genes to acquire new functions (Fig. 
3B-D). Indeed, LTR sequences frequently act as promoters for host genes (Cohen et al., 
2009). One example of a TE-derived promoter generating a cell-type specific isoform of a 
host gene with novel properties is mouse Dicer1 (Flemr et al., 2013). Dicer1 encodes an 
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RNA endonuclease that generates small regulatory RNAs during oogenesis and in other cell 
types. However, due to an intragenic insertion of an MT-C ERV retrotransposon, a truncated 
form of mouse Dicer1 is expressed specifically in oocytes. This truncated ERV-driven form of 
Dicer1, which is essential for oogenesis, lacks a potentially autoinhibitory helicase domain 
present in the N-terminal region of the full-length protein and is more enzymatically active 
than full-length Dicer1 (Flemr et al., 2013). Many genes in mouse oocytes and zygotes are 
similarly expressed from ERV insertions acting as promoters for nearby genes (Peaston et 
al., 2004), including Gata4 and Tead4, which encode key transcription factors that drive the 
specification of primitive endoderm and trophectoderm, respectively (Macfarlan et al., 2012). 
It will be of interest to investigate if there are additional examples in which co-option of ERV 
promoters modifies the function of host genes in cells. Interestingly, the expression of 
selected TE-derived transcripts can be used to track cell types during development and 
possibly also in adult tissues (see Box 1).	  
ERVs are also able to drive host gene expression in differentiating somatic tissues. 
Transcription of Bglap3, which encodes an osteocalcin-related protein, originates from a 
nearby IAP element in mouse ESCs and in some differentiated somatic tissues (Ecco et al., 
2016). The regulation of Bglap3 expression depends on the activity of a KRAB-ZFP that 
targets KAP1 and H3K9me3 repressive histone modifications to this IAP element, and 
conditional deletion of either the KRAB-ZFP or KAP1 post-natally in the liver results in 
transcriptional activation of Bglap3 in a tissue where it is normally repressed (Ecco et al., 
2016). In sum, the developmental regulation of KRAB-ZFPs, and potentially other regulators 
of TE expression, can therefore impact on host gene expression via the regulation of ERVs 
in embryonic development but also in fully differentiated somatic tissues. Furthermore, some 
ERVs appear to acquire epigenetic silencing marks early in development that maintain their 
repression even when KRAB-ZFPs or the KAP1 co-repressor is deleted later in differentiating 
tissues (Rowe et al., 2013; Rowe et al., 2010; Wolf et al., 2015a).  
Variable epigenetic silencing of ERV-derived alternative promoters in somatic tissues 
can also contribute to the regulation of host genes. This mechanism is exemplified by the 
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mouse Agouti gene. Agouti encodes a signaling molecule that is expressed in hair follicles 
and inhibits the Mc1r melanocortin receptor in melanocytes (Voisey and van Daal, 2002). 
During the hair growth cycle, a burst of Agouti expression causes melanocytes to change the 
type of melanin they produce from black eumelanin to yellow phaeomelanin, resulting in a 
sub-apical yellow band on an otherwise black hair (Blewitt and Whitelaw, 2013). A naturally 
occurring mouse mutant exhibiting an insertion of an IAP element immediately 5' and 
antisense to the first coding exon of Agouti produces mice with yellow coats. A cryptic 
antisense promoter in this IAP element drives constitutive expression of functional Agouti 
transcripts in these mutants (Michaud et al., 1994), but variable DNA methylation of this IAP 
element between individuals means that these genetically identical mice display a continuous 
spectrum of coat colour phenotypes from yellow to agouti. Offspring arising from yellow 
mothers, but not yellow fathers, are more likely to have yellow coats suggesting that there 
can be some trans-generational inheritance of the epigenetic state of this IAP insertion 
(Morgan et al., 1999). Thus, mechanisms that regulate ERV expression are able to impact on 
ERV promoter-driven host gene expression and the development of somatic tissues.	  
SINE and LINE-1 TEs can also act as alternative promoters to drive the expression 
of host genes (Fig. 3B,D). SINE elements typically contain an internal RNA polymerase III 
promoter that transcribes these elements, but some also carry an active RNA polymerase II 
promoter that drives transcription in an anti-sense orientation (Lai et al., 2009). Transcripts 
originating from the anti-sense RNA polymerase II promoter in these elements can drive the 
expression of nearby host genes (Ferrigno et al., 2001). Full-length LINE-1s contain 
conserved sense and an anti-sense promoters (Speek, 2001; Swergold, 1990), and recent 
studies have shown that the anti-sense promoter in primate LINE-1 drives the expression of 
a trans-acting polypeptide, ORF0, that can stimulate LINE-1 mobilization in trans (Fig. 3D) 
(Denli et al., 2015). For some host genes, the majority of their transcripts in induced 
pluripotent stem cells (iPSCs) originate from a nearby LINE-1 antisense promoter and 
contain ORF0 peptide sequences that can be spliced on to the host-derived protein (Denli et 
al., 2015). 
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The exaptation of TEs as alternative promoters thus appears to be a relatively simple 
way to alter the pattern or level of expression of host genes during development (Fig. 3). 
There are also examples of convergent exaptation of TEs as promoters of specific 
developmental genes. In some mammals, the gene encoding the hormone prolactin is 
expressed in the pituitary gland but is also expressed from an alternative promoter in the 
maternal endometrial decidua during pregnancy, regulating immune cells, angiogenesis and 
invasion of the fetal placenta into maternal tissues (Jabbour and Critchley, 2001). In humans, 
the transcription of decidual prolactin initiates from an upstream MER39 ERV. In contrast, the 
transcription of decidual prolactin in mice originates from a MER77 ERV located further 
upstream, whereas elephants transcribe decidual prolactin from an elephant-specific LINE-1 
insertion (Emera et al., 2012; Emera and Wagner, 2012). Thus, the independent evolution of 
TE-derived prolactin promoters at multiple points in mammalian evolution suggests that TEs 
provide a rich source of transcription factor binding sites that allows host genes to acquire 
expression and function in new cell types and tissues (Fig. 3).	  
 
TEs as tissue-specific enhancers of host genes	  
In addition to acting as promoters that drive the expression of alternative isoforms of 
host genes, transcription factor binding sites within TEs can act as host gene enhancers in 
specific tissues or developmental contexts (Fig. 3B, D). Indeed, conserved non-exonic TEs 
in the human genome tend to cluster within 1 Mb of developmental genes and transcriptional 
regulators, suggesting that this may be a common mechanism for TEs to impact mammalian 
development (Lowe et al., 2007). Several examples of TEs acting as enhancers have been 
noted. In trophoblast stem cells, for example, the mouse-specific RLTR13 ERV recruits the 
trophoblast transcription factors Eomes, Cdx2 and Elf5, and appears to act as a trophoblast 
enhancer for around 100 host genes (Chuong et al., 2013). ERV-derived enhancers have 
also been reported in developing primordial germ cells (Liu et al., 2014), and in ESCs 
(Kunarso et al., 2010). TEs, particularly ERVs, are present in 5-25% of the genomic regions 
bound by pluripotency-associated transcription factors OCT4 or NANOG in human and 
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mouse ESCs, and in mouse ESCs ERV elements provide binding sites for the pluripotency-
associated transcription factor SOX2 (Bourque et al., 2008; Kunarso et al., 2010).	  
Additionally, TEs, especially ERVs, are also able to act as tissue-specific enhancers in the 
innate immune system (Fig. 3B, D), where they act to mediate part of the interferon 
response (see Box 2). 	  
SINEs are also able to act as enhancers for host genes, particularly during brain 
development. The gene encoding the LIM homeobox transcription factor ISL1, which is 
required for motor neuron development, has a nearby conserved exapted LF-SINE TE 
insertion that can drive gene expression in neural tissues (Bejerano et al., 2006). Similarly, 
AmnSINE1 TE insertions are associated with genes involved in brain development, such as 
FGF8, and act as neural-specific enhancers in transgenic mice (Sasaki et al., 2008). 	  
DNA transposons, too, can act as enhancers to influence host gene expression and 
contribute to gene regulatory networks in development, even though they no longer mobilize 
in most mammals. The MER130 DNA transposon appears to act as a neocortical enhancer 
for a number of genes involved in neural development including Robo1 and Id4 (Notwell et 
al., 2015). Similarly, DNA transposons are strongly represented amongst the large number of 
TEs that contribute to gene regulatory networks in the mammalian endometrium during 
pregnancy. The MER121 and MER97C DNA transposons are enriched in regions bound by 
activated progesterone receptor in human endometrial cells and appear to contribute to 
progesterone-responses in this tissue (Lynch et al., 2015). 	  
 
TEs as regulators of chromosome organization	  
In addition to their more direct roles in regulating host gene expression, TEs can 
influence the organization of mammalian chromosomes. One of the major regulators of 
mammalian chromosome organization is CTCF, which can act as an insulator to block the 
interaction between an enhancer and a promoter, as a barrier to prevent the spreading of 
chromatin domains, and as an anchor that assembles chromatin into loops or domains within 
which regulatory elements can interact (reviewed in (Merkenschlager and Nora, 2016)). In 
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combination with cohesin, CTCF plays an important role in allowing developmental 
enhancers to regulate gene expression, particularly in the context of long-range enhancers 
(Fig. 3D) (Merkenschlager and Odom, 2013). TEs are strongly enriched within regions of 
mammalian genomes that bind CTCF, and in mice B2 SINEs are enriched in these regions 
and carry a CTCF binding motif (Bourque et al., 2008; Schmidt et al., 2012; Sundaram et al., 
2014). One example of a context in which a B2 SINE insertion influences developmental 
gene regulation through effects on chromatin domains occurs during the expression of 
growth hormone (GH) in the developing pituitary (Lunyak et al., 2007). During the early 
stages of pituitary development, when GH is not expressed, a repressive chromatin domain 
extends across the GH locus. However, this domain becomes restricted as pituitary 
development proceeds. A boundary element located upstream of GH marks the edge of the 
chromatin domain, and a B2 SINE TE in this region is both necessary and sufficient for the 
insulating activity that prevents repressive chromatin from extending into the GH domain 
during late pituitary development (Lunyak et al., 2007). The insulating activity of this SINE TE 
requires its RNA polymerase II and RNA polymerase III transcripts, suggesting that 
bidirectional transcription of this element causes a local change in chromatin structure that 
prevents repressive chromatin from spreading across it (Lunyak et al., 2007; Ponicsan et al., 
2010). Notably, additional examples of human and rodent SINEs containing defined 
transcription factor binding sites have been previously documented (Morales-Hernandez et 
al., 2016; Roman et al., 2011). Future research will help to define the full-repertoire of effects 
that TEs can exert on mammalian chromosome organization.   
 
The domestication of TE-derived proteins and processes in development	  
TEs can also impact on mammalian development through their proteins becoming 
domesticated, i.e. performing functions for the host organism. The human genome contains 
around fifty genes that are probably domesticated TEs (Lander et al., 2001). One developing 
tissue that appears to rely significantly on domesticated TEs is the placenta. Domestication 
of Gag-Pol regions of sushi-ishi-derived ERVs has generated the paternally imprinted Peg10 
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and Peg11 genes that have essential functions in mouse placenta development. Peg10 plays 
a role in the development of the trophectoderm-derived spongiotrophoblast and labyrinth 
layers of the placenta, the latter being the site in which components are exchanged between 
maternal and fetal circulatory systems (Ono et al., 2006), while Peg11 functions in 
extraembryonic mesoderm-derived endothelial cells that line the fetal capillaries of the 
placenta. Domestication of the Env regions of ERVs has also generated genes with essential 
functions for placenta development. The fetal capillaries in the labyrinth are surrounded by 
syncytial trophoblast cells that play an important role in allowing the exchange of 
components of the maternal and foetal circulatory systems. This epithelial layer is formed via 
inter-cellular fusion between trophoblast cells in a process involving proteins known as 
syncytins (Dupressoir et al., 2009; Dupressoir et al., 2011). These syncytins are co-opted 
fusogenic Env proteins derived from ERVs (Blond et al., 2000; Mi et al., 2000). Remarkably, 
mouse, human and rabbits have all independently co-opted Envs from different ERVs to act 
as syncytins, and independent capture of syncytins has occurred at least six times during 
mammalian evolution (Dupressoir et al., 2012). Even marsupials, which have a relatively 
transient placenta that is in contact with the maternal endometrium for a short period of time, 
may have domesticated a fusogenic placentally-expressed ERV Env protein (Cornelis et al., 
2015).	  
DNA transposons can also undergo domestication, as exemplified by the RAG1 and 
RAG2 genes that have essential functions during development of the adaptive immune 
system (see Box 2). Finally, in what may be a form of domestication, recent data suggests 
that LINE-1 retrotransposons may have a present day function during oogenesis in mice as a 
quality control mechanism that eliminates defective oocytes, suggesting a function for LINE-1 
in regulating the ovarian oocyte pool (Malki et al., 2014). The ovarian oocyte pool gradually 
declines with age, and the size of the oocyte pool at birth is thought to be a major 
determinant of reproductive success in older women. It will therefore be of interest to test if 
LINE-1 plays a similar role in human oogenesis. 	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Diversification of the mammalian transcriptome by TEs	  
TEs often insert into introns or untranslated regions of genes, and this can 
sporadically result in the exonization of TEs (Fig. 3B). Indeed, exonized TEs can expand the 
mammalian transcriptome and proteome but can also be used to fine tune gene regulation 
(Piriyapongsa et al., 2007a). The accumulation of TE-derived sequences in cellular mRNAs 
can lead to their differential regulation due to TE control mechanisms targeting these TE-
portions or structures (Heras et al., 2014; Heras et al., 2013).  Notably, several classes of 
TEs have been found inserted within mammalian RNAs (Piriyapongsa et al., 2007a; 
Piriyapongsa et al., 2007b; Zarnack et al., 2013) and it is likely that their presence may 
impact gene regulation and function by providing or interfering with regulatory elements in 
those RNAs (Fig. 3).	  	  
Another way that TEs diversify the mammalian transcriptome is by generating long 
non-coding RNAs (lncRNAs) from their promoters (Fig. 3D). Remarkably, almost 2/3 of all 
known human lncRNAs contain TE fragments in their sequences (Kapusta et al., 2013; 
Macia et al., 2011). LncRNAs are more abundant than known genes and are involved in 
multiple biological processes including gene regulation, maintenance of nuclear architecture 
and splicing (Macia et al., 2015; Mercer et al., 2009; Moran et al., 2012). The existence of 
functional lncRNAs was discovered in the early 1990’s, with the characterization of the Xist – 
a lncRNA involved in X chromosome inactivation ((Brown et al., 1992), reviewed in (Moran et 
al., 2012)). This X chromosome-encoded lncRNA is thought to interact with LINE-1 elements 
to bring about X chromosome inactivation in females (Lyon, 2003). LINE-1 elements are 
over-represented on the X chromosome (Lander et al., 2001), and it has been suggested that 
evolutionary older silent LINE-1 elements are involved in assembling a Xist-dependent 
repressive domain on the inactive X chromosome, while evolutionary younger transcribed 
LINE-1 elements help spread this repressive domain into adjacent chromosomal regions 
(Chow et al., 2010). The over-representation of LINE-1s on the X chromosome may therefore 
reflect a present-day function for these sequences in X chromosome inactivation. 
17	  	  
Intriguingly, despite a lack of sequence conservation, unexpected roles for multiple 
human and mouse TE-derived lncRNAs in regulating pluripotency have also recently been 
described (Fort et al., 2014; Guttman et al., 2011; Lu et al., 2014). Multiple mechanisms may 
be involved, and some of these TE-derived lncRNAs represent transcripts originating from 
ERV elements acting as enhancers or promoters in these cells (Fort et al., 2014). However, 
lncRNAs derived from HERV-H ERVs in human ESCs appear to act in trans via physical 
association with chromatin modifiers (Guttman et al., 2011; Lu et al., 2014; Wang et al., 
2014). Future research will likely reveal how these diverse species-specific TE-derived 
sequences can regulate conserved developmental processes.	  
TEs can also influence developmental processes in trans through the LINE-1-
dependent generation of processed pseudogenes (Esnault et al., 2000). Although LINE-1 
encoded proteins tend to bind to their encoding mRNA in cis (Esnault et al., 2000; Wei et al., 
2001) (Fig. 2A), they occasionally bind to cellular host mRNAs in trans and catalyze their 
insertion into the genome as processed pseudogenes (Fig. 3C). Over evolution, mammalian 
genomes have accumulated more processed pseudogenes than annotated genes (Zhang et 
al., 2004). Although most inserted processed pseudogenes lack a functional promoter upon 
insertion, a promoter can evolve, be captured by a new TE insertion, or be generated by 
recombination resulting in a new functional gene (Ji et al., 2015) (Fig. 3C). In dogs, the 
expression of a LINE-1-generated pseudogene derived from the FGF4 gene is strongly 
associated with a short-legged phenotype selected in dogs (Parker et al., 2009). Thus, the 
activity of TEs can mediate the duplication and subsequent diversification of key 
developmental regulators. 
Finally, ongoing LINE-1 retrotransposition itself can generate new genes by a 
mechanism termed exon shuffling (Moran et al., 1999). Exon shuffling occurs when an active 
LINE-1 within a gene retrotransposes to a new genomic location and delivers nearby coding 
sequences to the new locus. Indeed, LINE-1-mediated exon shuffling has likely increased the 
repertoire of the human proteome but, due to frequent 5’ truncation during retrotransposition 
(Grimaldi et al., 1984; Kazazian et al., 1988), its overall contribution to the human genome 
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remains elusive. Notably, known examples of LINE-1-exon shuffling generated genes have 
been found in primate species, and include the generation of a new gene product that can 
restrict HIV infection in new world monkeys (Sayah et al., 2004).	  
 
LINE-1 activity in humans  
LINE-1 elements, which are the only active autonomous retrotransposons in 
humans, are thought to mobilize during at least two different developmental contexts: the 
early embryo and the developing/adult brain (Hancks and Kazazian, 2016; Munoz-Lopez et 
al., 2016; Richardson et al., 2015). By contrast, the expression and mobilization of TEs in 
other somatic cells in humans appears to be low. 
 
Retrotransposition in the early embryo	  
Studies of transgenic mice carrying engineered human LINE-1 retrotransposition 
reporters suggests that LINE-1 mobilizes in pre-implantation embryos (Kano et al., 2009; 
Muotri et al., 2005). Some of this LINE-1 mobilization could potentially reflect activity in the 
trophectoderm, which gives rise to the extra-embryonic component of the placenta (Fig. 4A). 
Indeed, the placenta has more limited TE restriction mechanisms than other hypomethylated 
cell types (Reichmann et al., 2013), although LINE-1 mobilization in these cell types has not 
been directly assessed. However, at least some of the LINE-1 mobilization in pre-
implantation embryos occurs in the pluripotent epiblast, which gives rise to all embryonic 
tissues (Fig. 4A). Notably, such LINE-1 mobilization in pluripotent cells in pre-implantation 
embryos could result in the new insertion being a mosaic within somatic and germline cells in 
adults.  
LINE-1 is also highly expressed, and new insertions of endogenous LINE-1 and 
LINE-1 reporters can accumulate, in human pluripotent cell lines that mimic some aspects of 
embryonic pluripotent cells (Garcia-Perez et al., 2007; Garcia-Perez et al., 2010; Klawitter et 
al., 2016; Wissing et al., 2011; Wissing et al., 2012). The LINE-1 transcripts expressed in 
pluripotent cell lines represent a restricted subset of the genomic LINE-1 repertoire, 
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suggesting that the surrounding chromatin environment of a LINE-1 locus might contribute to 
local activation of these elements in this cell type (Karimi et al., 2011; Macia et al., 2011; 
Philippe et al., 2016). Notably, the analysis of a new LINE-1 insertion in humans is also 
consistent with mobilization of this element occurring in pluripotent cells early in 
embryogenesis (van den Hurk et al., 2007). However, the frequency and specific timing of 
when retrotransposition takes place in early embryos and during gametogenesis remain to 
be determined.  
 
Retrotransposition in the brain 
Both endogenous and engineered LINE-1s have also been shown to mobilize in the 
mammalian brain (Fig. 4A) (Muotri et al., 2005). Surprisingly, LINE-1 mRNAs are expressed 
in neuronal precursor cells (NPCs) in the mammalian brain and new LINE-1 insertions can 
accumulate in NPCs, at least in mouse models of human LINE-1 retrotransposition and in 
cultured human NPCs (Fig. 4A) (Coufal et al., 2009; Muotri et al., 2005). Notably, a study 
that analyzed LINE-1 expression in fetal NPCs and in other somatic cells (skin) isolated from 
the same donor demonstrated that a subtle change in LINE-1 promoter DNA methylation 
levels in brain cells might explain why LINE-1 mRNAs are expressed selectively in NPCs 
when compared to other tissues such as skin (Fig. 4A) (Coufal et al., 2009). However, the 
availability of transcription factors can also contribute to this phenomenon (Richardson et al., 
2014a; Thomas et al., 2012). 
More recently, the development of next generation DNA sequencing and single cell 
genomics-based studies have allowed researchers to demonstrate that the human brain is in 
fact made of a mosaic of genomes (Baillie et al., 2011; Erwin et al., 2016; Evrony et al., 
2012; Evrony et al., 2015; Upton et al., 2015), although there is an ongoing debate about the 
frequency of retrotransposition in this tissue (Evrony et al., 2016; Richardson et al., 2014a). 
Furthermore, while retrotransposition has been proposed to be ubiquitous in the 
hippocampus of the human brain (Upton et al., 2015), we know little about other brain 
regions or neuronal cell types that may support elevated levels of retrotransposition. 
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Nonetheless, it is clear that the ongoing activity of LINE-1s in the brain could provide a 
mechanism to ensure that no two human brains - even those of identical twins - are 
genetically identical.  
The functional impact of LINE-1 retrotransposition in the brain is less clear 
(Richardson et al., 2014a; Singer et al., 2010). Indeed, it is possible that LINE-1 expression 
and mobilization in the brain could be a consequence of LINE-1 elements having a present 
day function as enhancers or promoters for host genes in this tissue. However, it is possible 
that LINE-1 activity in mammalian brains might be on its way to domestication and that, like 
the domestication of DNA transposons in the immune system, the ability of TEs to increase 
genetic diversity beyond that encoded by the germline genome is providing some benefit to 
the development or function of this highly complex organ. Constructing a map of LINE-1 
expression and retrotransposition in the different human brain areas and cellular types will 
help understand both the magnitude and impact of somatic retrotransposition on brain 
biology.  
LINE-1 retrotransposition in the brain is potentially mutagenic, although de novo 
somatic LINE-1 insertions disrupting brain development or function in patients remains to be 
demonstrated. Recent studies suggest that the ongoing activity of LINE-1s in the healthy 
brain can result in the generation of genomic rearrangements that could delete genomic 
regions proximal to genes, although any functional significance remains to be determined 
(Erwin et al., 2016). Similarly, it remains to be elucidated whether dysregulated LINE-1 
expression or retrotransposition could contribute to brain disorders, although data acquired in 
models of Rett syndrome, Ataxia Telangiectasia and Schizophrenia suggest that 
retrotransposition is indeed associated with these syndrome (Bundo et al., 2014; Coufal et 
al., 2011; Muotri et al., 2010) (reviewed in (Richardson et al., 2014a)).	  
 
The expression and mobilization of TEs in other somatic human cells	  
The description of LINE-1 activity in the human brain raises another important 
question: are LINE-1 elements expressed and mobilized in other somatic tissues? Although 
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more research is needed, several studies suggest that the somatic activity of TEs might be 
restricted to the human brain. Notably, in a recent study it was reported that human tissues 
including esophagus, prostate, stomach and heart muscle express relatively low levels of 
LINE-1 mRNAs whereas expression in the adrenal gland, kidney, spleen and cervix was 
below the detection limit (Belancio et al., 2010). Whether part of the expressed LINE-1 
mRNAs corresponds to active retrotransposition-competent LINE-1 mRNAs is unknown. 
More recently, and exploiting the inherent capability of human ESCs to differentiate into 
somatic stem cells, the expression level of human LINE-1s as well as putative engineered 
LINE-1 retrotransposition has been explored in a panel of human somatic stem/progenitor 
cells, including human NPCs, human mesenchymal stem cells (MSCs), hematopoietic stem 
cells (HSCs) and progenitor keratinocytes (Macia et al., 2016) (Fig. 4B). These data suggest 
that NPCs are the only analyzed population of somatic stem/progenitor cells in which LINE-1 
expression levels are significant (Macia et al., 2016). In addition, efficient retrotransposition 
was only detected in NPCs and mature neuronal cells (Macia et al., 2016) (Fig. 4B). These 
data suggest that retrotransposition in human somatic tissues might be restricted to the brain 
(Baillie et al., 2011; Erwin et al., 2016; Evrony et al., 2012; Evrony et al., 2015; Macia et al., 
2016; Upton et al., 2015). However, additional research is required to define if additional 
LINE-1-dependent TEs are also mobilising in the human brain, the extent of that mobilization, 
and to fully understand the phenotypic consequences of TE activity in the human brain.	  
 
Conclusions	  
While our understanding of the precise role of TE expression and mobilization during 
human development still remains limited, recent studies have provided key insights into the 
regulation of TEs. Indeed, future studies analysing the impact that the ongoing activity of TEs 
during embryogenesis and in the adult brain exert, in a healthy or disease genetic 
background, will shed light into the unknown functions of TEs in normal mammalian 
development and biology. Recent studies suggest that there are multiple ways in which a TE 
derived sequence, either at the RNA or DNA level, can affect gene regulatory networks and 
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gene function during mammalian development. Thus, these present day functions of TEs 
may underlie their abundance in mammalian genomes by providing a convenient mechanism 
for host genes to evolve new expression patterns and isoforms. In addition, independent 
convergent exaptation of different TEs as developmentally-regulated gene regulatory 
sequences has occurred in multiple mammalian species during evolution, and TE 
domestication has been key in generating a functional placenta. In the future, additional 
genomics and genome-wide epigenetic maps from multiple cell types across multiple 
species, in combination with CRISPR/Cas9-driven functional genomics, will more clearly 
define the role of TEs in mammalian development. 
Notably, the existence of active TEs in mammals implies that the mammalian body is 
a mosaic of gene regulatory networks. On one hand, the mobilization of TEs during early 
embryogenesis results in the generation of mosaic bodies with respect to their TE content. 
Whether this mosaicism impacts on human homeostasis or predisposition to disease is 
currently unknown. Future studies exploiting single-cell genomics and animal models of de-
regulated retrotransposition will clearly help to define the contribution of active TEs to 
mammalian biology and disease. On the other hand, in humans LINE-1 mobilization is not 
equally distributed in the body and seems to be restricted to the brain, suggesting that any 
functional consequences of LINE-1 mobilization are likely impacting on this tissue. The 
somatic activity of LINE-1 generates genetic variation in the human brain and it is possible 
that this activity might be undergoing domestication in mammals. However, many questions 
remain unanswered: can LINE-1s move equally well in all neuronal and glial cell types 
present in a vertebrate brain? Do all vertebrate species contain active TEs in their brains? 
And of course, the most important question in current TE biology: what is the role of the 
somatic activity of TEs in the vertebrate brain? 	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Boxes 
 
Box 1. Using TEs as markers of cell identity or fate 
The expression of individual TEs can be used to distinguish and/or isolate specific cell types 
during development. For example, the knowledge that MERVL ERVs are highly expressed in 
totipotent 2-cell stage mouse zygotes has recently been used to isolate sub-populations of 
ESCs in culture with totipotent rather than pluripotent developmental potential (Macfarlan et 
al., 2012). A similar strategy has been used to show that depletion of the chromatin assembly 
factor CAF1 promotes the generation of 2-cell-like cells from mouse ES cells (Ishiuchi et al., 
2015). Similarly, the transcription of select primate-specific ERVs has also been used to 
isolate populations of naïve-like pluripotent stem cells from human ESCs cultures (Wang et 
al., 2014). It will be of interest to see whether this approach may facilitate the identification of 
other transient or low abundance cell populations in developing tissues. 	  
Box 2. TEs in the immune system 
TEs can function as tissue-specific enhancers in the innate immune system, acting to 
mediate the response to interferons, which are pro-inflammatory signalling molecules that 
are secreted in response to infection, inhibit viral replication in nearby cells and activate 
immune cells. Specific TEs are enriched close to genes that are activated by interferon 
(interferon-stimulated genes, ISGs) in human cells (Chuong et al., 2016). One of the most 
enriched TEs, MER41B ERV, contains interferon-inducible binding sites for the STAT1 
transcription factor, which mediates part of the interferon response (Chuong et al., 2016).  A 
MER41B insertion upstream of AIM2, a human ISG, is required for AIM2 expression in 
response to interferon, and deletion of this element impairs the anti-viral response of human 
cell lines (Chuong et al., 2016).  Interestingly, there is no copy of MER41B upstream of AIM2 
in mice, and AIM2 is constitutively expressed rather than interferon-inducible in this species. 
Notably, RLTR30B ERVs in mice also contain interferon-inducible STAT1 binding sites and 
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are enriched near functionally annotated immunity genes in this species (Chuong et al., 
2016). It's possible that the infectious ancestors of these ERVs possessed interferon-
inducible STAT1-binding sites in order to exploit the host's innate immune system to promote 
their own transcription, and that this innovation has now been repeatedly and independently 
co-opted by mammals in order to drive evolution of the innate immune system (Chuong et 
al., 2016).  
Domesticated TEs also play a role in the generation of antibody repertoires during 
development of the adaptive immune system (Teng and Schatz, 2015). The breaking and 
rejoining of DNA molecules that occurs during diversification of antibody genes by V(D)J 
recombination has some similarities to the cut-and-paste mobilization of DNA transposons 
(Melek et al., 1998; Teng and Schatz, 2015; van Gent et al., 1996). Indeed, it has been 
suggested that the RAG1 and RAG2 genes that are required for V(D)J recombination in 
developing lymphocytes were derived nearly 500 million years ago from a Transib 
superfamily DNA transposon (Kapitonov and Jurka, 2005). The domestication of TE-derived 
sequences in this developmental context thus appears to play an important role in increasing 
genetic diversity in this somatic lineage beyond that encoded by the germline genome. 	  	   	  
26	  	  
	  
Figure Legends 
 
Figure 1. The structures of key classes of TEs found in mammalian genomes. 
 Different types of TEs (DNA transposons; LINE-1, long interspersed element class 1; SINE, 
short interspersed element; ERV, endogenous retrovirus) found in mammalian genomes are 
represented. The percentage of the human and mouse genomes occupied by each TE is 
indicated in blue. Abbreviations: IR, inverted repeat; UTR, untranslated region; EN, 
endonuclease; RT, reverse transcriptase; LTR, long terminal repeat; ORF, open reading 
frame. 
 
Figure 2. Modes of TE mobilization in mammalian genomes 
(A) The LTR retrotransposition cycle (adapted from (Mager and Stoye, 2015)). The ERV 
RNA is transcribed from the 5’ LTR and transported to the cytoplasm, where Gag and Pol are 
translated and processed into mature proteins including protease, integrase and reverse 
transcriptase (not shown in the figure but see (Mager and Stoye, 2015) for further details). 
These ERV proteins and RNAs are then packaged into a virus-like particle (VLP; blue opal 
surrounded by Gag molecules) and reverse-transcribed (RT) by Pol. The resulting ERV 
dsDNA is then processed by the integrase activity of Pol to generate a pre-integration 
complex (PIC), which is imported to the nucleus. Here, the integrase activity of Pol inserts 
the ERV dsDNA into the genome. New ERV insertions are often flanked by target site 
duplications (blue or green arrowheads). Host factors (HF; pink circles) also participate in 
several steps of the retrotransposition process. (B) The non-LTR retrotransposition cycle 
(adapted from (Macia et al., 2015)). The full-length active LINE-1 RNA is transcribed and 
transported to the cytoplasm where ORF1p and ORF2p are translated (Alisch et al., 2006; 
Dmitriev et al., 2007). These proteins preferentially bind to their encoding mRNA, generating 
a ribonucleoprotein particle (RNP), which is imported into the nucleus. The EN activity of 
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ORF2p generates a single strand (SS) break in genomic DNA that is used by the RT activity 
of ORF2p to generate the first strand cDNA (red arrow). How second strand synthesis occurs 
is not well understood. New LINE-1 insertions are often flanked by TSDs (blue or green 
arrowheads) and are also often 5’-truncated (not shown). As is the case for the LTR 
retrotransposition cycle, host factors (pink circles) are involved in several steps of the non-
LTR retrotransposition process. 
 	  
Figure 3. The impact of TEs on mammalian genomes.  
(A) Deleterious effects of TE insertions on host gene expression. A cartoon of a host gene 
containing an upstream promoter (black arrow), exons (blue tubes) and introns (grey lines) is 
shown. TEs are inserted in sense or antisense orientations (blue arrows). Red arrows on TEs 
denote promoter sequences. Various RNA transcripts (wavy lines) can be produced, based 
on the location/orientation of the TE and the promoter used. The left side indicate the type of 
mechanism that is responsible for the generation of each type of transcript. Asterisk indicates 
a premature termination codon or frameshift. For full details see main text. (B) De novo TE 
insertions (grey) can impact genes (blue) in various ways. Shown are examples where a new 
TE insertion can act as: i) an enhancer; ii) a TE insertion within the gene body can lead to 
exonization of the TE and this can lead to a new protein product with an alternative function; 
iii) additionally, exonized TE sequences can induce premature termination of translation 
(PTC, premature termination codon); and iv) a full-length TE insertion within the gene can 
generate a shorter gene transcript when the TE promoter is used (new transcript) that could 
have an alternative function. t, denotes evolutionary time. (C) LINE-1 elements can generate 
processed pseudogenes. Shown are a cellular gene (green) and an active LINE-1 (blue). 
Upon transcription (mRNAs, green and blue lines) and translation, the LINE-1 RNP can 
generate a new insertion by conventional cis retrotransposition. However, the cellular RNA 
could be occasionally transferred to the LINE-1 RNP, generating a gene RNP that can be 
inserted into the genome by trans retrotransposition. The potential consequences are 
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indicated below: i) using a nearby promoter (red arrow), a new transcript (grey/green wavy 
line) can be generated and this can have an alternative function or could also interfere with 
the regulation of the parental gene; ii) the pseudogene can acquire mutations (red lines and 
dots in the pseudogene) over evolution and thus acquire a new cellular function. t, denotes 
evolutionary time. (D) TE insertions can impact gene regulation and chromosome 
architecture. The cartoon shows the possible outcomes of a gene (A, purple) that 
accumulated two new TE insertions. The upstream TE, if full-length, could generate 
antisense transcripts (grey wavy line) that act as long non coding RNAs (New lncRNAs) or 
that could be translated into a protein product as recently described (New protein (LINE-1 
ORF0) (Denli et al., 2015)). Note that these antisense RNAs could also alter chromosome 
architecture and gene regulation by interfering with: gene A (cis interference) or with a gene 
located elsewhere in the genome (gene B, green, trans interference).  Additionally, the 
upstream TE can generate new chimeric RNAs (grey/purple wavy line) that can induce 
deregulation of gene A expression (altered expression) or that could induce expression of 
gene A in a different cell type (altered cell type expression). Similarly, the TE inserted within 
the gene could also generate antisense RNAs (purple wavy line) that can interfere with gene 
A regulation (antisense expression and gene regulation). Finally, the TE inserted within the 
gene can generate a chimeric RNA using the TE promoter (grey/purple wavy line) that could 
have an alternative function (chimeric RNA and alternative function). 	  
 
Figure 4. LINE-1 expression and activity in humans: from tissues to cells. (A) TE and 
LINE-1 (L1) expression and activity during embryogenesis and in adult humans. Pre-
implantation, post-implantation embryos and a scheme of an adult human are shown. (B) 
LINE-1 (L1) expression and activity in different types of cultured human stem cells are 
shown. The developmental relationships between these cell types are also shown. In A and 
B, each blue box indicate the level of TE/L1 expression. On top of each box, it is indicated if 
new insertions in each tissue/cell type can be transmitted to the next generation (Heritable) 
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or not (Somatic). Data on embryogenesis has been mostly analysed using mouse models, 
while expression in adult tissues has been analysed using mostly human samples. 
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